Ambry Most Genetic Counselors Encounter Discrepant Variant Classifications, Must Work Out Interpretations Premium While neither common nor rare, discrepant variant classification can affect the management of patient care, and there are efforts to improve interpretations. Ambry Genetics, Lightbeam Health Solutions Form Genetic Testing Data Partnership The collaboration is aimed at helping various organizations to predict patients' increased risk for common cancers and chronic conditions. Konica Minolta Precision Medicine, Amazon Web Services Partner for Diagnostic Data Platform Under the five-year agreement, Amazon has made an undisclosed investment in KMPM and is supporting the firm's Lattice integrated diagnostic data platform. BRCA2 Variants of Unknown Significance Reclassified Through Functional Data Additions Researchers reclassified 86 percent of variants initially determined to be VUS, potentially changing surveillance or treatment approaches for patients. Ambry Genetics Gets FDA Emergency Use Authorization for Coronavirus Test The test uses primers and probes from Thermo Fisher Scientific's authorized TaqPath COVID-19 Combo Kit with a modified results interpretation algorithm. Dec 9, 2020 Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project Sep 17, 2020 Scipher Medicine Taps Ambry Genetics to Scale Up TNF Inhibitor Response Test Jun 4, 2020 Studies Show Potential of Video, Online Education to Expand Cancer Risk Genetic Test Access Premium May 20, 2020 Volpara Solutions, Ambry Genetics Form Breast Cancer Management Alliance Mar 24, 2020 Germline Genetic Testing, Counseling Move Remote as Pandemic Limits In-Person Care Capacity Mar 6, 2020 Ambry Genetics +RNA Insight Validation Data Suggests Notable Improvement in Diagnostic Yield Premium Jan 30, 2020 Illumina Puts Spotlight on Clinical NGS Opportunities, Cites Contributions to Coronavirus Response Premium Dec 18, 2019 Ambry Genetics, Mayo Clinic Develop Mutation Prevalence Tool to Guide Docs on Appropriate Testing Premium Dec 16, 2019 Ambry Genetics Gains NYS Approval for Paired RNA, DNA Genetic Test Dec 4, 2019 Ambry Genetics, Caris Life Sciences Partner on Cancer Genetic Testing Oct 23, 2019 Ambry Genetics Study Finds RNA Testing Can Clarify Role of Variants in Hereditary Cancer Genes Oct 4, 2019 Adding RNA-Seq, Ambry Genetics Expects to Reduce VUS Results in Hereditary Cancer Tests Premium Sep 5, 2019 Large-Scale Multigene Panel Study of Hereditary Cancer Risk Refines Gene Associations Premium Jun 4, 2019 Color Panel Reveals Hereditary Cancer Risk in Trinidad and Tobago Breast Cancer Patients Premium Apr 5, 2019 Ambry Researchers Report Consequences of RNA-Based Variant Reclassification at ACMG Mar 22, 2019 Confirmatory Testing, Insurance Coverage Growing Alongside DTC Genetic Testing Premium Mar 18, 2019 My Gene Counsel, Ambry Genetics Partner on DTC Genetic Test Verification Mar 8, 2019 New Memorial Sloan Kettering Tool Simplifies Curation of Germline Variants Using ACMG Guidelines Premium Feb 4, 2019 Clinical Utility of Polygenic Risk Scores Questioned in Commentary Premium Jan 22, 2019 Labs, Advocacy Groups Push Back on Medicare Policy Shift on NGS Testing for Hereditary Cancer Risk Premium Load More Breaking News Hamilton, Pacific Biosciences Partner on Automating DNA Sample Prep Danaher Q4 Revenues Rise 21 Percent COVID-19 Severity Biomarker Candidates Revealed in RNA Sequencing Study Flatiron Health, Japanese Hospital Partner on Real-World GI Cancer Database Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent Molecular Diagnostics Firm Mainz Biomed Prices $22.5M Follow-on Share Offering The Scan Time to Act A new report urges the UK to consider regulations to protect against the misuse of genomic technologies, according to the Guardian. Fulgent Seeking Defamation Suit Fulgent Genetics says it plans to sue Los Angeles County Sheriff Alex Villanueva for defamation, the Los Angeles Times reports. Speeding Gene-Edited Crops Reuters reports that China's new trial rules will make it easier to grow gene-edited crops there. Nucleic Acids Research Papers on Viral Recombination, Pan-Cancer Mutations, SARS-CoV-2 Variability In Nucleic Acids Research this week: updated pipeline to detect viral recombination, mutational patterns in tumor samples, and more.